IL-9 and Th9 cells: Progress and challenges

International Immunology

Volumn 25, Issue 10, 2013, Pages 547-551

  Zhao, Picheng ^a   Xiao, Xiang ^a   Ghobrial, Rafik M ^a   Li, Xian C ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Allergy; IL 9; Inflammation; Th9

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 9; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN 4 RECEPTOR;

AIRWAY; ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CANCER MODEL; CD4+ T LYMPHOCYTE; CELL TYPE; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MELANOMA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH9 CELL; ANIMAL; BODILY SECRETIONS; CELL DIFFERENTIATION; HYPERSENSITIVITY; IL-9; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAST CELL; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; TH9;

ALLERGY; IL-9; INFLAMMATION; TH9;

ANIMALS; BODILY SECRETIONS; CELL DIFFERENTIATION; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-9; LYMPHOCYTE ACTIVATION; MAST CELLS; RECEPTOR CROSS-TALK; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884730124     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt039     Document Type: Article

References (48)

1. Van Snick, J., Goethals, A., Renauld, J. C. et al. 1989. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J. Exp. Med. 169:363.
2. Li, X. C., Schachter, A. D., Zand, M. S. et al. 1998. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. Transplantation 66:265.
3. Knoops, L. and Renauld, J. C. 2004. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22:207.
4. h9 and allergic disease. Immunology 127:450.
5. h9 cells: differentiation and disease. Immunol. Rev. 252:104.
6. Dugas, B., Renauld, J. C., Pène, J. et al. 1993. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur. J. Immunol. 23:1687.
7. Petit-Frere, C., Dugas, B., Braquet, P. and Mencia-Huerta, J. M. 1993. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 79:146.
8. Hültner, L., Druez, C., Moeller, J. et al. 1990. Mast cell growthenhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol. 20:1413.
9. Renauld, J. C., Vink, A., Louahed, J. and Van Snick, J. 1995. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300.
10. Uyttenhove, C., Simpson, R. J. and Van Snick, J. 1988. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl Acad. Sci. USA 85:6934.
11. Stephens, G. L., Swerdlow, B., Benjamin, E. et al. 2011. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organspecific autoimmune disease. Eur. J. Immunol. 41:952.
12. Eller, K., Wolf, D., Huber, J. M. et al. 2011. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J. Immunol. 186:83.
13. Noelle, R. J. and Nowak, E. C. 2010. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10:683.
14. Nowak, E. C., Weaver, C. T., Turner, H. et al. 2009. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206:1653.
15. Lu, L. F., Lind, E. F., Gondek, D. C. et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997.
16. Wilhelm, C., Hirota, K., Stieglitz, B. et al. 2011. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12:1071.
17. Harrington, L. E., Hatton, R. D., Mangan, P. R. et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123.
18. Murphy, K. M. and Reiner, S. L. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933.
19. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10:857.
20. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
21. O'Shea, J. J. and Paul, W. E. 2010. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098.
22. h9 cells and their products. Crit. Rev. Immunol. 32:1.
23. Veldhoen, M., Uyttenhove, C., van Snick, J. et al. 2008. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341.
24. h9 development. J. Immunol. 188:968.
25. Dardalhon, V., Awasthi, A., Kwon, H. et al. 2008. IL-4 inhibits TGFbeta- induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9:1347.
26. Chang, H. C., Sehra, S., Goswami, R. et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11:527.
27. Staudt, V., Bothur, E., Klein, M. et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33:192.
28. Chang, H. C., Han, L., Jabeen, R., Carotta, S., Nutt, S. L. and Kaplan, M. H. 2009. PU.1 regulates TCR expression by modulating GATA-3 activity. J. Immunol. 183:4887.
29. Chang, H. C., Zhang, S., Thieu, V. T. et al. 2005. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22:693.
30. Xiao, X., Balasubramanian, S., Liu, W. et al. 2012. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat. Immunol. 13:981.
31. Ansel, K. M., Djuretic, I., Tanasa, B. and Rao, A. 2006. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24:607.
32. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.
33. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821.
34. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. 2008. Regulatory T cells and immune tolerance. Cell 133:775.
35. Perumal, N. B. and Kaplan, M. H. 2011. Regulating Il9 transcription in T helper cells. Trends Immunol. 32:146.
36. Schmitt, E., Beuscher, H. U., Huels, C. et al. 1991. IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 147:3848.
37. Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H. and Dong, C. 2010. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11:250.
38. Blom, L., Poulsen, B. C., Jensen, B. M., Hansen, A. and Poulsen, L. K. 2011. IL-33 induces IL-9 production in human CD4+ T cells and basophils. PLoS One 6:e21695.
39. Li, X. C., Rothstein, D. M. and Sayegh, M. H. 2009. Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229:271.
40. Elyaman, W., Bassil, R., Bradshaw, E. M. et al. 2012. Notch receptors and Smad3 signaling cooperate in the induction of interleukin- 9-producing T cells. Immunity 36:623.
41. Amsen, D., Antov, A., Jankovic, D. et al. 2007. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27:89.
42. Fang, T. C., Yashiro-Ohtani, Y., Del Bianco, C., Knoblock, D. M., Blacklow, S. C. and Pear, W. S. 2007. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27:100.
43. Fu, Y., Chang, A., Chang, L. et al. 2009. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J. Biol. Chem. 284:19452.
44. Yang, X. O., Zhang, H., Kim, B. S. et al. 2013. The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat. Immunol. 14:732.
45. Nicolaides, N. C., Holroyd, K. J., Ewart, S. L. et al. 1997. Interleukin 9: a candidate gene for asthma. Proc. Natl Acad. Sci. USA 94:13175.
46. Jones, C. P., Gregory, L. G., Causton, B., Campbell, G. A. and Lloyd, C. M. 2012. Activin A and TGF-β promote T(H)9 cellmediated pulmonary allergic pathology. J. Allergy Clin. Immunol. 129:1000.
47. h9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122:4160.
48. Purwar, R., Schlapbach, C., Xiao, S. et al. 2012. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18:1248.